Neudle.com: demyelinating disease tissue culture studies in

Differential
(Click to cross reference)

abducens nerve paralysis

abducens nerve paralysis, bilateral

abscess, intracerebral

abscess, intracerebral, multiple

abscess, sphenoid sinus

acquired immunodeficiency syndrome

adverse drug reaction

agitation

alcoholism

algorithm

alveolar hypoventilation

aneurysm, fungal intracranial

angiitis

animal exposure

anorexia

anti basal ganglia antibodies

anti Hu antibody

anti MAG antibodies

anticonvulsants, untoward effects of

antistreptolysin titer

aspartate aminotransferase

autoimmune encephalopathy

autoimmune GFAP astrocytopathy

autonomic dysfunction

autonomic neuropathy

bacteremia

bacterial infection, CNS

basal ganglia

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

behavioral disorder, acute

bone marrow transplantation

brainstem, infarction of

brainstem, lesion of

brainstem, tuberculoma of

bulbar palsy

carcinoma

carcinoma of lung

cardiac transplantation

CAT scan, abnormal

CAT scan, contrast enhanced, subepend.

CAT scan, myelogram with

catatonia

cauda equina, enhancement

cauda equina, lesion of

cavernous sinus, lesion of

CD4 counts

central nervous system, infection of

cerebellar lesion

cerebellitis

cerebellitis, autoimmune

cerebral cortex

cerebral embolism

cerebral infarction

cerebral infarction, hemorrhagic

cerebritis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, complement of

cerebrospinal fluid, culture of

cerebrospinal fluid, culture of, viral

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, leak

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, pressure low

cerebrospinal fluid, proteincytologic dissociation

cerebrospinal fluid, red cells in

cerebrospinal fluid, xanthochromia of

cerebrovascular accident

cerebrovascular accident, silent

chemotherapy, CNS treatment and complications with

Clinical Pathologic Conference(C.P.C.)

cognition

collagen vascular disease

confusional state, acute

congestive heart failure

conjunctivitis

conus medullaris, lesion of

corpus callosum

corpus callosum, lesion of

cost effectiveness

cranial nerve palsies

cranial neuropathy, multiple

cyclophosphamide

cytochrome c oxidase

cytomegalovirus infection

demyelinating disease

demyelinating disease, tissue culture studies in

dentate nuclei

dentate nuclei, lesion of

differential diagnosis

diplopia

disability, neurological

dyskinesia, buccal lingual facial

dysphagia

dystonia

echocardiogram

electroencephalogram, abnormalities of

encephalitis lethargica

encephalitis, autoimmune

encephalitis, etiology

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

encephalomyelitis, parainfectious

encephalomyelitis, postinfectious

encephalopathy

endocarditis

endocarditis, acute bacterial

endocarditis, infectious

enuresis

epidemiology of neurology

epidural blood patch

episodic neurologic deficits

epistaxis

Epstein-Barr virus

experimental allergic encephalitis

fluorescent treponema antibody absorption/false positive

foscarnet

fundus, abnormality of

fungal infection

fungal infection, CNS

gadolinium

gammaglobulin therapy, intravenous

ganciclovir

ganglionitis

gaze palsy, horizontal

gender

GFAP-IgG

glutamic acid decarboxylase, antibody

granulomatosis with polyangiitis

granulomatous disease

Guillain Barre syndrome

hallucination

hallucination, visual

hemianopia, homonymous

heralding manifestation

herpes encephalitis

herpes virus

herpes virus infection

Hodgkin's disease, neurologic involvement with

Horner's syndrome

H-reflex testing

human herpesvirus 6

human immunodeficiency virus type 1

iatrogenic neurologic disorders

imbalance

immune checkpoint inhibitors

immune-related adverse events

immunohistochemistry

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

inappropriate antidiuretic(A.D.H.)hormone

intracerebral hemorrhage

intracranial hypertension, benign

intracranial hypotension

intravenous

intravenous line

keratitis

leg weakness, bilateral

lethargy

leukemia

leukemia, neurologic findings assoc.with

level of consciousness, decreased

limbic encephalitis

limbic system

listeria monocytogenes

listeriosis, CNS

liver disease

liver function enzymes

liver transplantation

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

medulla oblongata, lesion of

memory, defect of recent

memory, impairment of

meningeal enhancement

meningismus

meningitis

meningitis, aseptic

meningitis, bacterial

meningitis, bacterial-negative CSF culture

meningitis, chronic

meningitis, iatrogenic

meningitis, listeria monocytogenes

meningitis, lupus

meningitis, neurologic aspects and complications of

meningitis, noninfectious

meningitis, predisposing factors in

meningitis, recurrent

meningitis, spinal fluid smear and culture-negative

meningitis, treatment of

meningoencephalitis

meningoencephalomyelitis

mental status, abnormal

microabscesses, cerebral

monoclonal antibodies

mononeuropathy

mononeuropathy multiplex

MRI, contrast enhanced

MRI, contrast enhanced, subependymal

MRI, cortical enhancement

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, negative

MRI, pelvis

MRI, spinal cord

MRI, sulcal hyperintensity

multiple myeloma

multiple sclerosis

multiple sclerosis, diagnosis of

myelitis, longitudinal

nasal septum, perforation of

nausea and vomiting

neck pain

negative

neoplasm, primary of CNS

neoplastic angioendotheliosis

nephritis

nerve conduction studies

nerve root biopsy

nerve root enhancement

nerve root hypertrophy

neurexin-3 alpha antibodies

neurologic disease

neurologic disease, diagnoses of

neurologic examination, focal

neurologic signs

neurolymphomatosis

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuropathology

neuropathy

neuropathy, motor, multifocal

neuropathy, peripheral

neuropathy, peripheral, treatment

neuropathy, vasculitic, systemic

ophthalmoplegia, plus syndrome

opportunistic infection

opportunistic infection, CNS

optic nerve, infarction of

optic neuritis

optic neuropathy, ischemic

optic neuropathy, ischemic, anterior

orbit

orbit, pseudotumor of

organ transplantation

otitis, neurologic complications with

Parkinsonism syndrome

paroxysmal neurologic disorder

peripheral blood stem cell transplantation

perivascular enhancement

plasma cell dyscrasia

plasma cell myeloma, CNS involvement associated with

plasmapheresis

pleocytosis of cerebrospinal fluid

pleocytosis of cerebrospinal fluid, neutrophilic

poliomyelitis

poliomyelitis-like illness

polymerase chain reaction

polyneuropathy

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

post transplant lymphoproliferative disease

posterior inferior cerebellar artery syndrome

potassium channel antibodies

primary intracranial hypotension

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

psychiatric problems in neurologic disorders

pulmonary infiltrates

radiation therapy, CNS treatment and complications with

remote effect of cancer on the nervous system

renal failure

renal transplantation

respirator

retinal artery occlusion

retinopathy

reversible neurologic disorder

review article

rhabdomyolysis

rheumatoid arthritis

rheumatoid arthritis factor(R.A.factor)

Sabin-Feldman dye test

scleroderma, neurologic involvement with

scotoma

sedimentation rate

sedimentation rate, elevated

seizure

seizure, children

seizure, focal

seizure, psychomotor-temporal lobe

seizure, treatment of

sella turcica, enlargement of

septicemia

serologic testing

serologic testing of cerebrospinal fluid

seronegative

serum alanine aminotransferase

sexual behavior, disorder of

sinuses, diseases of

sinusitis

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

skin, tight

sleep pathology and physiology

slurred speech

somnolence

speech disorder

spinal cord, lesion of

splenomegaly

standing difficulty

staphylococcus aureus

stem cell rescue

stem cell transplantation

steroid

steroid responsive encephalopathy

steroid therapy, CNS treatment and complications with

striatal encephalitis

striatum, lesion of

striatum, lesion of, bilateral

subarachnoid hematoma, spinal

subarachnoid hemorrhage

subdural hematoma

subdural hygroma

suprasellar lesion

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

tachycardia

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamus, lesion of-bilateral

third nerve palsy

tinnitus

tongue, fasciculations of

toxic encephalopathy

toxoplasmosis, acquired

toxoplasmosis, CNS

transient ischemic attack

treatment of neurologic disorder

tremor

tremor, postural

trigeminal neuropathy

trigeminal neuropathy, sensory

tuberculoma of CNS

tuberculosis

tuberculosis, miliary

water channel antibodies

weakness

weakness, generalized

white matter disease, periventricular

Showing articles 950 to 1000 of 2180 << Previous Next >>

Is Hospitalization After TIA Cost-Effective on the Basis of Treatment With tPA?
Neurol 65:1799-1801, Nguyen-Huynh,M.N. &Johnson,S.C., 2005

tPA By Telephone: Extending the Benefits of a Comprehensive Stroke Center
Neurol 64:154-156, Frey,J.L.,et al, 2005

Telemedicine for Safe and Extended Use of Thrombolysis in Stroke
Stroke 36:287-291, Audebert, H.J., et al, 2005

Aggressive Mechanical Clot Disruption
Stroke 36:292-296, Noser, E.A., et al, 2005

Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005

Combined IV and intra-arterial thrombolysis for acute ischemic stroke
Neurol 64:386-388, Flaherty, M.L., et al, 2005

Clinical and Imaging Predictors of Intracerebral Haemorrhage in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
JNNP 76:70-75, Derex,I.,et al, 2005

Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005

Time to Hospital Arrival, Use of Thrombolytics, and In-Hospital Outcomes in Ischemic Stroke
Neurol 64:2115-2120, Qureshi,A.I.,et al, 2005

Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia
Stroke 36:1441-1446, Daffertshofer,M.,et al, 2005

Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
Stroke 36:1512-1518, Wojner-Alexandrov,A.,et al, 2005

Predictors of Early Arterial Reocclusion After Tissue Plasminogen Activator-Induced Recanalization in Acute Ischemic Stroke
Stroke 36:1452-1456, Rubiera,M.,et al, 2005

Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke, Results of the MERCI Trial
Stroke 36:1432-1440, Smikth,W.D.,et al, 2005

Lymphocytic Choriomeningitis Virus Infection in Organ Transplant Recipients-Massachusetts, Rhode Island, 2005
MMWR 54:537-539, , 2005

Gnathostomiasis-Neuroimaging of Larval Migration
NEJM 353:2, , 2005

Clinicopath Conf,Encephalomyelitis Due to West Nile Virus and CLL, Case 22-2005
NEJM 353:287-295, Hollande,H.,et al, 2005

Pediatric Central Nervous System Posttransplant Lymphoproliferative Disorder
AJNR 26:1695-1697, Brennan,.C.,et al, 2005

West Nile Virus Among Blood Donors in the United States, 2003 and 2004
NEJM 353:451-459,516, Stramer,S.L.,et al, 2005

Intravenous rt-PA for Acute Stroke: Comparing Its Effectiveness in Younger and Older Patients
JNNP 76:1234-1237, Mouradian,M.S.,et al, 2005

MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke 36:1939-1943, Kang,D.-W.,et al, 2005

REACH Clinical Feasibility of a Rural Telestroke Network
Stroke 36:2018-2020, Hess,D.C.,et al, 2005

Agressive Therapy With Intravenous Abciximab and Intra-Arterial rtPA and Additional PTA/Stenting Improves Clinical Outcome in Acute Vertebrobasilar Occlusion
Stroke 36:1160-1165, Eckert,B.,et al, 2005

Perfusion Computed Tomography: Prediction of Final Infarct Extent and Stroke Outcome
Ann Neurol 58:672-679,661, Parsons,M.W.,et al, 2005

Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States
Stroke 36:2500-2503, Demaerschalk,B.M. &Yip,T.R., 2005

Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke 36:2497-2499, Smith,E.E.,et al, 2005

Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (=80 Years) Stroke Patients
Stroke 36:2421-2425, Berrouschot,J.,et al, 2005

Clinical Importance of Microbleeds in Patients Receiving IV Thrombolysis
Neurol 65:1175-1178, Kakuda,W.,et al, 2005

Tuberculous Meningitis in BCG Vaccinated and Unvaccinated Children
JNNP 76:1550-1554,1470, Kumar,R.,et al, 2005

Acute Disseminated Encephalomyelitis
Arch Neurol 62:1673-1680, Menge,T.,et al, 2005

Posterior Cerebral Artery Stroke
e medicine, Hill,M.D., 2005

Stroke or Encephalitis?
Emerg Med Australas 17:401-404, Townend,B.S.,et al, 2005

Do the Brain Attack Coalition's Criteria for Stroke Centers Improve Care for Ischemic Stroke?
Neurol 64:422-427, Douglas, V.C., et al, 2005

Intraocular Haemorrhage after Thrombolysis
Lancet 365:330, Kaba, R.A., et al, 2005

Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005

Prioritizing interventions to Improve Rates of Thrombolysis for Ischemic Stroke
Neurol 64:654-659, California Acute Stroke Pilot Registry (CASPR) Inv, 2005

Reasons for Exclusion From Thrombolytic Therapy Following Acute Ischemic Stroke
Neurol 64:719-720, Cocho,D., et al, 2005

Fatal Avian Influenza A (H5N1) in a Child Presenting with Diarrhea Followed by Coma
NEJM 352:686-691, de Jong,M.D., et al, 2005

Clinicopath Conf, Acute Myelogenous Leukemia Presenting as Meningitis
NEJM 352:274-283, Case 2-2005, 2005

Transmission of Rabies Virus from an Organ Donor to Four Transplant Recipients
NEJM 352:1103-11, Srinivasan,A., et al, 2005

Sonothrombolysis in Acute Ischemic Stroke for Patients Ineligible for rt-PA
Neurol 64:1052-1054, Eggers,J., et al, 2005

Prospective Reliability of the Stroke Doc Wireless/Site Independent Telemedicine System
Neurol 64:1058-1060, Meyer,B.C., et al, 2005

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 36:916-921, Adams,H.,et al, 2005

Acute Disseminated Encephalomyelitis
Arch Neurol 62:650-652, Lindzen,.E.,et al, 2005

Reversal of Warfarin-Induced Anticoagulation with Factor VIIa Prior to rt-PA in Acute Stroke
Neurol 64:1480-1481, Talkad,A.,et al, 2005

Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome
AJNR 26:880-884, Zaidat,O.O.,et al, 2005

Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005

IV Thrombolysis in Patients with Acute Stroke Due to Spontaneous Carotid Dissection
Neurol 64:1612-1614, Georgiadis,D.,et al, 2005

Utility of an Ultrafast Magnetic Resonance Imaging Protocol in Recent and Semi-Recent Strokes
JNNP 76:1002-1005,905, U-King-Im,J.M.,et al, 2005

Showing articles 950 to 1000 of 2180 << Previous Next >>